Newsroom

NEW YORK--(BUSINESS WIRE)--KBRA assigns preliminary ratings to 6 classes of mortgage-backed notes from GS Mortgage-Backed Securities Trust 2026-HE2 (GSMBS 2026-HE2), a $308.9 million RMBS transaction sponsored by Goldman Sachs Mortgage Company (Goldman Sachs or GSMC), consisting of first lien (10.9%) and second lien (89.1%) home equity line of credit (HELOC) loans. The underlying pool is seasoned approximately six months and comprises 3,088 loans, with United Wholesale Mortgage, LLC (UWM; 44.3%...

MONTRÉAL--(BUSINESS WIRE)--À l’approche de la rentrée, l’une des plus importantes périodes de magasinage de produits technologiques de l’année, les habitudes d’achat évoluent au Québec. Un nouveau sondage mené pour le compte de Best Buy Canada révèle que plus de la moitié (56 %) de la population québécoise se tourne vers des produits technologiques remis en circulation, une catégorie qui englobe les produits remis à neuf, boîte ouverte ou issus d’un programme d’échange. À l’approche du retour e...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF - November 14.08.2026 GNOV LN IE000OJ31JQ4 1,000,002.00 USD  37,550,375.24   37.550  ...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of AtaiBeckley Inc. (NasdaqGM: ATAI) to Eli Lilly and Company (NYSE: LLY). Under the terms of the proposed transaction, shareholders of AtaiBeckley will receive $6.75 per share in cash, plus up to $2.50 per share in the form of a Contingent Value Right entitling the holder to additional cash payments u...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Vest U.S. Equity Moderate Buffer UCITS ETF- August 14.08.2026 GAUG LN IE000TGSG3Y5  350,002.00 USD  13,157,200.15   37.592  ...

SEATTLE--(BUSINESS WIRE)--Expedia's Fall Travel Outlook finds that travelers may need to be more strategic to score a seasonal deal this year. Summer demand has spilled into fall, with prices in the top 10 U.S. destinations averaging 20% higher for lodging and 2% higher for flights when comparing fall to summer. [1] [2] As a result, traditional shoulder-season savings are harder to find in many popular destinations. Despite the trend in pricing, Expedia® identified six destinations where travel...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 14.08.2026 SCAR LN IE000BW2B3J3   50,002.00 USD   1,551,994.73   31.039  ...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until October 12, 2026 to file lead plaintiff applications in a securities class action lawsuit against HDFC Bank Limited (“HDFC” or the “Company”) (NYSE: HDB), if they purchased or otherwise acquired the Company’s securities between July 17, 2023 and May 26, 2026, inclusive (the “Class Pe...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Arcosa, Inc. (NYSE: ACA) to CRH (NYSE: CRH). Under the terms of the proposed transaction, shareholders of Arcosa will receive $150.00 in cash for each share of Arcosa that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the con...

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Crinetics Pharmaceuticals, Inc. (NasdaqGS: CRNX) to Vertex Pharmaceuticals Incorporated (NasdaqGS: VRTX). Under the terms of the proposed transaction, shareholders of Crinetics will receive $85.00 in cash for each share of Crinetics that they own. KSF is seeking to determine whether this considerati...